BACKGROUND:The Silk Vista Baby (SVB) is a low profile flow diverter increasingly used to treat intracranial aneurysms (IAs), especially those in small caliber distal vessels. However, the available evidence remains limited and heterogeneous in terms of design, patient selection, use of adjunctive coiling, and follow-up protocols. PURPOSE:To systematically evaluate the safety and efficacy of SVB for IA treatment. DATA SOURCES:PubMed, Scopus, and Web of Science were searched following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)guidelines. STUDY SELECTION:Studies were included if they reported ≥5 patients with IAs treated with SVB, and provided clinical and angiographic outcome data. DATA ANALYSIS:Efficacy endpoints included adequate/complete occlusion and retreatment rates. Safety outcomes included good functional outcome (modified Rankin Scale score of 0-2), procedure related complications, morbidity, mortality, in-stent stenosis, and covered branch occlusion. Pooled proportions with 95% CIs were calculated using a random effects model. RESULTS:14 observational studies (13 retrospective; one prospective) including 653 patients (65.4% women; mean age 55.3±4.4 years) with 673 aneurysms were included. Most aneurysms were unruptured (59.6%). Adequate and complete occlusion at the last follow-up was 82.68% (95% CI 75.52 to 89.85) and 71.39% (95% CI 60.78 to 82.00), respectively. Retreatment occurred in 1.46% (95% CI 0.00 to 3.16). Good functional outcome was reported in 92.90% of cases. Procedure related complications occurred in 9.32%, with 0.53% morbidity and 0.37% mortality. In-stent stenosis occurred in 7.18% of cases. Immediate covered branch occlusion occurred in 5.38% of patients, and covered branch occlusion at follow-up in 17.69%, mostly asymptomatic. CONCLUSIONS:In observational studies, SVB showed favorable angiographic and clinical outcomes for selected distal intracranial aneurysms. However, the available evidence was limited by retrospective study design, substantial heterogeneity, and variable follow-up, and conclusions, particularly in ruptured aneurysms, and should be interpreted with caution pending prospective comparative data. TRIAL REGISTRATION:PROSPERO CRD420251171696.
BACKGROUND:Posterior circulation (PC) aneurysms are associated with a higher risk of rupture. Flow diverters (FDs) are widely used for carotid intracranial aneurysms, but their role in PC aneurysms is less established. This meta-analysis examines the available literature on the safety and effectiveness of FDs for PC aneurysms. METHOD:We conducted a systematic search from database inception until October 2024. The primary effectiveness outcome was complete occlusion rate defined by the Raymond-Roy and/or O'Kelly-Marotta scales. Primary safety outcomes included thromboembolic event rates following implantation. Secondary outcomes included procedure-related mortality, good functional outcome (GFO), and retreatment. Pool estimates were calculated using a random-effect model. Subgroup analysis based on morphology and study design was also conducted. RESULTS:A total of 42 studies met our inclusion criteria. A total of 1698 patients were treated with FDs for 1760 PC aneurysms. Among these cases, 47.6% were in the vertebral artery. Our pooled overall analysis of complete occlusion rates was 72.73% (P<0.0001; I2=67.2%), and the pooled thromboembolic events rate following implantation was 11.70% (P<0.0046; I2=70.5%). Additionally, the pooled mortality rate was 8.07% (P<0.0001; I2=61.5%), the retreatment rate was 6.59% (P<0.4260; I2=1%), and the pooled GFO rate was 83.99% (P<0.0001; I2=76%). Subgroup analysis revealed that fusiform-dolichoectatic had a complete occlusion rate of 48.29% (P<0.3223; I2=11.7%). CONCLUSION:FDs for PC aneurysms achieve generally adequate occlusion rates, except in dolichoectatic-fusiform subtypes. Despite achieving adequate occlusion rates, FD use was associated with higher thromboembolic events, mortality, and retreatment rates, which necessitates careful patient selection.
Adhesive capsulitis, also known as frozen shoulder, is characterized by progressive pain and loss of shoulder mobility due to capsular inflammation and fibrosis. This is a case of a 50‑year‑old postmenopausal woman with a history of Graves' disease treated by radio‑iodine ablation who presented with a year‑long history of gradually worsening left‑shoulder pain and stiffness. Imaging revealed mild acromioclavicular arthrosis and supraspinatus tendinosis without rotator cuff tear, findings consistent with adhesive capsulitis. Conservative management with physiotherapy, home exercise, and non‑steroidal anti‑inflammatory drugs provided little relief, and a subacromial corticosteroid injection gave temporary improvement. The patient subsequently underwent ultrasound‑guided glenohumeral hydrodistention combined with a suprascapular nerve block and intra‑articular corticosteroid, allowing for immediate pain relief and increased passive range of motion, enabling more effective participation in physical therapy. This case shows how thyroid imbalance and reduced estrogen may jointly contribute to capsular fibrosis and demonstrates that hydrodistention with a nerve block can be used as an effective treatment for adhesive capsulitis refractory to conservative management. Early identification of endocrine and hormonal risk factors may facilitate timely intervention and improve outcomes for patients with frozen shoulder.
Robotic microsurgery offers greater precision compared to manual surgical techniques and enables vascular anastomoses at submillimeter scales. This pilot study evaluated the incorporation of the Synaptix® Digital Surgery Platform, which provides a real-time system information overlay displaying essential data such as instrument status, motion scaling, and recovery details, with the Symani® Surgical System for microvascular anastomosis. Three surgeons (plastic surgery, neurosurgery, and head and neck) performed 1–2 mm synthetic vessel anastomoses using Symani alone and Symani with Synaptix. Metrics included Anastomosis Time, Teleoperation Exits, Re-Entry Time, Re-Entry Attempts, Assistant Use, and Exit Reason Match (alignment between system-logged and surgeon-identified explanations for each teleoperation exit event). Compared with Symani alone, mean Anastomosis Time was numerically shorter with Symani + Synaptix (20
The Artisse intrasaccular device (Medtronic) offers a novel treatment option for unruptured and ruptured wide-neck bifurcating intracranial aneurysms.1 2The Artisse device features enhancements including a distal tip for dome protection, platinum band markers for improved visibility, and a bilayer high-density platinum core nitinol mesh basket for enhanced flexibility and visibility when compared with previous devices.2–7 Data from case series demonstrate the procedural safety and efficacy of the Artisse device.1 2 This versatile flared-shape intrasaccular device can be used alongside products such as the Rebar microcatheter 18 and Navien.2 In Europe, an adequate occlusion rate of 78% at 12 months and 79.2% at 36 months follow-up has been shown.3 8 This video documents the embolization of a wide-neck unruptured anterior communicating artery aneurysm using the Artisse device, where Sim&Size was used for proper sizing (video 1).4 9 The procedure was uneventful, achieving successful device deployment with no parent vessel compromise.Video 1Artisse intrasaccular device for intracranial aneurysm treatment—first in the USA